Loading...
Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
Bivalent rLP2086 (Trumenba), a vaccine for prevention of Neisseria meningitidis serogroup B (NmB) disease, was licensed for use in adolescents and young adults after it was demonstrated that it elicits antibodies that initiate complement-mediated killing of invasive NmB isolates in a serum bacterici...
Na minha lista:
| Udgivet i: | mBio |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5850321/ https://ncbi.nlm.nih.gov/pubmed/29535195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mBio.00036-18 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|